All charts and data below are CPI-U inflation-adjusted and with dividends reinvested. (Why?)
DNA real return snapshot: after CPI-U inflation, DNA returned −33.27% over the past year and −8.42% YTD, with dividends reinvested. Since Apr. 19, 2021, DNA is down −98.46% in real purchasing-power return, or −53.70%/yr, and is currently −98.91% below its real total-return high on Nov. 8, 2021.
Data ending Fri Sep. 18, 2026
| Mon 2021-04-19💬 to Fri 2026-09-18 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| DNA × |
−98.46%
−53.70%/yr |
−58.99%/yr
R2=0.906 |
||||
| Ginkgo Bioworks Holdings NYSE Common Stock | ||||||
| Mon 2021-04-19💬 to Fri 2026-09-18 |
Start
Value |
End
Value |
|---|---|---|
| DNA × |
$10,000.00
2021-04-19 |
$154.47
2026-09-18 |
| YTD | YoY | |
|---|---|---|
| DNA × | −8.42% | −33.27% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| DNA × |
−98.91%
on 2026-09-18 from 2021-11-08 peak |
−99.23%
on 2026-03-30 from 2021-11-08 peak |
| Period ending Fri 2026-09-18 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| DNA × | −33.27% |
−0.13% −0.07%/yr |
−90.24% −53.96%/yr |
−98.68% −57.91%/yr |
— |
| Year | DNA |
|---|---|
| 2026 (YTD) | −8.42% |
| 2025 | −17.58% |
| 2024 | −85.88% |
| 2023 | −3.24% |
| 2022 | −80.90% |
| 2021 | −21.58% |